A critical appraisal of the adjuvant chemotherapy guidelines for patients with completely resected T3N0 non-small-cell lung cancer

References

• Pisters KM, Evans WK, Azzoli CG, Kris MG, Smith CA, Desch CE, . Cancer Care Ontario and American Society of Clinical Oncology adjuvant chemotherapy and adjuvant radiation therapy for stages I-IIIA resectable non small-cell lung cancer guideline. J Clin Oncol 2007;25:5506–18.
   PubMed Web of Science ®Google Scholar
• Douillard JY, Rosell R, De Lena M, Carpagnano F, Ramlau R, Grodzki T, . Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): A randomised controlled trial. Lancet Oncol 2006;7:719–27.
   PubMed Web of Science ®Google Scholar
• Pignon JP, Tribodet H, Scagliotti GV, Douillard JY, Shepherd FA, Stephens RJ, . Lung adjuvant cisplatin evaluation: A pooled analysis by the LACE Collaborative Group. J Clin Oncol 2008;26:3552–9.
   PubMed Web of Science ®Google Scholar
• Mountain CF. A new international staging system for lung cancer. Chest 1986;89:S225–S233.
   PubMed Web of Science ®Google Scholar
• Goldstraw P, Crowley J, Chansky K, Giroux DJ, Groome PA, Rami-Porta R, . The IASLC Lung Cancer Staging Project: Proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours. J Thorac Oncol 2007; 2:706–14.
   PubMed Web of Science ®Google Scholar
• Strauss GM, Herndon J E, Maddaus MA. Adjuvant chemotherapy in stage IB non small cell lung cancer (NSCLC): Update of Cancer and Leukemia Group B (CALGB) protocol 19633. J Clin Oncol 2008;24:S36565(Suppl; abstr 7007).
   Google Scholar
• Hamada C, Tanaka F, Ohta M, Fujimura S, Kodama K, Imaizumi M, . Meta-analysis of postoperative adjuvant chemotherapy with tegafur-uracil in non-small-cell lung cancer. J Clin Oncol 2005;23:4999–5006.
   PubMed Web of Science ®Google Scholar
• Non-Small Cell Lung Cancer Collaborative Group. Chemotherapy in non-small cell lung cancer: A meta-analysis using updated data on individual patients from 52 randomised clinical trials. BMJ 1995;311:899–909.
   PubMed Web of Science ®Google Scholar
• George S, Schell MJ, Detterbeck FC, Socinski MA. Adjuvant chemotherapy for resected non-small cell carcinoma of the lung: Why we still don’t know. Oncologist 1998;3:35–44.
   PubMedGoogle Scholar
• Bria E, Felici A, Carlini P, Ferretti G, Nistico C, Cuppone F, . Adjuvant chemotherapy for non-small cell lung cancer: Pooled analysis of 3443 patients. Ann Oncol 2004; 15:A646 (Suppl 3).
   PubMedGoogle Scholar
• Hotta K, Matsuo K, Ueoka H, Kiura K, Tabata M, Tanimoto M. Role of adjuvant chemotherapy in patients with resected non-small-cell lung cancer: Reappraisal with a meta-analysis of randomized controlled trials. J Clin Oncol 2004;22:3860–7.
   PubMed Web of Science ®Google Scholar
• Sedrakyan A, Van Der MJ, O’Byrne K, Prendiville J, Hill J, Treasure T. Postoperative chemotherapy for non-small cell lung cancer: A systematic review and meta-analysis. J Thorac Cardiovasc Surg 2004;128:414–9.
   PubMed Web of Science ®Google Scholar
• Berghmans T, Paesmans M, Meert AP, Mascaux C, Lothaire P, Lafitte JJ, . Survival improvement in resectable non-small cell lung cancer with (neo)adjuvant chemotherapy: Results of a meta-analysis of the literature. Lung Cancer 2005;49:13–23.
   PubMed Web of Science ®Google Scholar
• Bria E, Gralla R, Raftopoulos H, Ferretti G, Felici A, Nistico C, . Does adjuvant chemotherapy improve survival in non small cell lung cancer (NSCLC)? A pooled-analysis of 6494 patients in 12 studies, examining survival and magnitude of benefit. J Clin Oncol 2005;23(Suppl):655s.
   PubMedGoogle Scholar
• Pignon JP, Tribodet H, Scagliotti GV, Douillard JY, Shepherd FA, Stephens RJ, . Lung Adjuvant Cisplatin Evaluation (LACE): A pooled analysis of five randomized clinical trials including 4,584 patients. J Clin Oncol 2006;24(Suppl):S366.
   Google Scholar
• Stewart LA, Burdett S, Tierney JF, Pignon J. Surgery and adjuvant chemotherapy (CT) compared to surgery alone in non-small cell lung cancer (NSCLC): A meta-analysis using individual patient data (IPD) from randomized clinical trials (RCT). J Clin Oncol 2007;25(Suppl):S397.
   Google Scholar
• Ichinose Y, Hara N, Ohta M, Motohiro A, Kuda T, Aso H. Postoperative adjuvant chemotherapy in non-small cell lung cancer: Prognostic value of DNA ploidy and post-recurrent survival. J Surg Oncol 1991;46:15–20.
   PubMed Web of Science ®Google Scholar
• Niiranen A, Niitamo-Korhonen S, Kouri M, Assendelft A, Mattson K, Pyrhonen S. Adjuvant chemotherapy after radical surgery for non-small-cell lung cancer: A randomized study. J Clin Oncol 1992;10:1927–32.
   PubMed Web of Science ®Google Scholar
• Feld R, Rubinstein L, Thomas PA. Adjuvant chemotherapy with cyclophosphamide, doxorubicin, and cisplatin in patients with completely resected stage I non-small-cell lung cancer. The Lung Cancer Study Group. J Natl Cancer Inst 1993; 85:299–306.
   PubMed Web of Science ®Google Scholar
• Ohta M, Tsuchiya R, Shimoyama M, Sawamura K, Mori T, Miyazawa N, . Adjuvant chemotherapy for completely resected stage III non-small-cell lung cancer. Results of a randomized prospective study. The Japan Clinical Oncology Group. J Thorac Cardiovasc Surg 1993;106:703–8.
   PubMed Web of Science ®Google Scholar
• Dautzenberg B, Chastang C, Arriagada R, Le Chevalier T, Belpomme D, Hurdebourcq M, . Adjuvant radiotherapy versus combined sequential chemotherapy followed by radiotherapy in the treatment of resected nonsmall cell lung carcinoma. A randomized trial of 267 patients. GETCB (Groupe d’Etude et de Traitement des Cancers Bronchiques). Cancer 1995;76:779–86.
   PubMed Web of Science ®Google Scholar
• Lee CG, Kim JH, Chung KY, Lee DY, Kim KD, Lee WY . A prospective randomized study of postoperative adjuvant chemo-radiotherapy (CT+RT) vs radiotherapy (RT) alone in resected stage II and IIIA non-small call lung cancer (NSCLC). Int J Radiat Oncol Biol Phys 1995;32:280(Suppl 1).
   Google Scholar
• Keller SM, Adak S, Wagner H, Herskovic A, Komaki R, Brooks BJ, . A randomized trial of postoperative adjuvant therapy in patients with completely resected stage II or IIIA non-small-cell lung cancer. Eastern Cooperative Oncology Group. N Engl J Med 2000;343:1217–22.
   PubMed Web of Science ®Google Scholar
• Mineo TC, Ambrogi V, Paci M, Iavicoli N, Pompeo E, Nofroni I. Transxiphoid bilateral palpation in video-assisted thoracoscopic lung metastasectomy. Arch Surg 2001;136: 783–8.
   PubMedGoogle Scholar
• Lee G-W, Kim S-W, Suh C, Kim WS, Kim DK, Park SI, . Prognostic significance of lympho/vascular tumor emboli at adjuvant chemotherapy setting in the patients with stage II, III non-small cell lung cancer after curative resection and postoperative thoracic radiotherapy. Proc Am Soc Clin Oncol 2003;21:649.
   Google Scholar
• Scagliotti GV, Fossati R, Torri V, Crino L, Giaccone G, Silvano G, . Randomized study of adjuvant chemotherapy for completely resected stage I, II, or IIIA non-small-cell Lung cancer. J Natl Cancer Inst 2003;95:1453–61.
   PubMed Web of Science ®Google Scholar
• Arriagada R, Bergman B, Dunant A, Le Chevalier T, Pignon JP, Vansteenkiste J. Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer. N Engl J Med 2004;350:351–60.
   PubMed Web of Science ®Google Scholar
• Tada H, Tsuchiya R, Ichinose Y, Koike T, Nishizawa N, Nagai K, . A randomized trial comparing adjuvant chemotherapy versus surgery alone for completely resected pN2 non-small cell lung cancer (JCOG9304). Lung Cancer 2004;43:167–73.
   PubMed Web of Science ®Google Scholar
• Winton T, Livingston R, Johnson D, Rigas J, Johnston M, Butts C, . Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer. N Engl J Med 2005; 352:2589–97.
   PubMed Web of Science ®Google Scholar
• Park JH, Lee CT, Lee HW, Baek HJ, Zo JI, Shim YM. Postoperative adjuvant chemotherapy for stage I non-small cell lung cancer. Eur J Cardiothorac Surg 2005;27:1086–91.
   PubMed Web of Science ®Google Scholar
• Logan DM, Lochrin CA, Darling G, Eady A, Newman TE, Evans WK. Adjuvant radiotherapy and chemotherapy for stage II or IIIA non-small-cell lung cancer after complete resection. Provincial Lung Cancer Disease Site Group. Cancer Prev Control 1997;1:366–78.
   PubMedGoogle Scholar
• Alam N, Darling G, Evans WK, Mackay JA, Shepherd FA. Adjuvant chemotherapy for completely resected non-small cell lung cancer: A systematic review. Crit Rev Oncol Hematol 2006;58:146–55.
   PubMed Web of Science ®Google Scholar
• Alam N, Darling G, Shepherd FA, Mackay JA, Evans WK. Postoperative chemotherapy in nonsmall cell lung cancer: A systematic review. Ann Thorac Surg 2006;81:1926–36.
   PubMed Web of Science ®Google Scholar
• Dillman RO, Seagren SL, Propert KJ, Guerra J, Eaton WL, Perry MC, . A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small-cell lung cancer. N Engl J Med 1990;323:940–5.
   PubMed Web of Science ®Google Scholar
• Osaka Lung Cancer Study Group. Postoperative adjuvant chemotherapy in non-small cell lung cancer: Results of a prospective randomized study. Jpn J Lung Cancer 1992; 32:11–22.
   Google Scholar
• Imaizumi, M. Postoperative adjuvant cisplatin, vindesine, plus uracil-tegafur chemotherapy increased survival of patients with completely resected p-stage I non-small cell lung cancer. Lung Cancer 1995;49:85–94.
   Google Scholar
• Wada H, Hitomi S, Teramatsu T. Adjuvant chemotherapy after complete resection in non-small-cell lung cancer. West Japan Study Group for Lung Cancer Surgery. J Clin Oncol 1996;14:1048–54.
   PubMed Web of Science ®Google Scholar
• Xu G, Rong T, Lin P. Adjuvant chemotherapy following radical surgery for non-small-cell lung cancer: A randomized study on 70 patients. Chin Med J (Engl) 2000;113:617–20.
   PubMed Web of Science ®Google Scholar
• Waller D, Peake MD, Stephens RJ, Gower NH, Milroy R, Parmar MK, . Chemotherapy for patients with non-small cell lung cancer: The surgical setting of the Big Lung Trial. Eur J Cardiothorac Surg 2004;26:173–82.
   PubMed Web of Science ®Google Scholar
• Tada H, Yasumitu T, Iuchi K, Taki T, Kodama K, Mori T, . Randomized study of adjuvant chemotherapy for completely resected non-small cell lung cancer: Lack of prognostic significance in DNA ploidy pattern at adjuvant setting. Proc Am Soc Clin Oncol 2002;21:Abstract 1250.
   Google Scholar
• Ueda H, Sakada T, Kuwahara M, Motohiro A. A small randomized phase III single-center trial on postoperative UFT administration in patients with completely resected non-small cell lung cancer. Anticancer Drugs 2004;15:29–33.
   PubMed Web of Science ®Google Scholar
• Karrer K, Pridun N, Denck H. Chemotherapy as an adjuvant to surgery in lung cancer. Cancer Chemother Pharmacol 1978;1:145–59.
   PubMed Web of Science ®Google Scholar
• Israel L, Bonadonna G, Sylvester R. Controlled study with adjuvant radiotherapy, chemotherapy, immunotherapy and chemoimmunotherapy in operable squamous carcinoma of the lung. In: Muggia F, Rozencweig M, editors. Lung cancer: Progress in therapeutic research. New York: Raven Press; 1979. 443–52.
   Google Scholar
• Shields TW, Higgins GAJ, Humphrey EW, Matthews MJ, Keehn RJ. Prolonged intermittent adjuvant chemotherapy with CCNU and hydroxyurea after resection of carcinoma of the lung. Cancer 1982;50:1713–21.
   PubMed Web of Science ®Google Scholar
• Girling DJ, Stott H, Stephens RJ, Fox W. Fifteen-year follow-up of all patients in a study of post-operative chemotherapy for bronchial carcinoma. Br J Cancer 1985;52:867–73.
   PubMed Web of Science ®Google Scholar
• Schallier DC, De Neve WJ, De Greve JL, Van Belle SP, De Wasch GJ, Dotremont G, . Is adjuvant treatment with vinblastine effective in reducing the occurrence of distant metastasis in limited squamous cell lung cancer? A randomized study. Clin Exp Metastasis 1988;6:39–48.
   PubMed Web of Science ®Google Scholar
• Trachtenberg A, Zakharchenkov AV, Zhiclov MA. Combined treatment including postoperative chemotherapy in lung cancer patients. Neoplasma 1988;35:351–9.
   PubMed Web of Science ®Google Scholar
• The Lung Cancer Study Group. The benefit of adjuvant treatment for resected locally advanced non-small-cell lung cancer. J Clin Oncol 1988;6:9–17.
   PubMed Web of Science ®Google Scholar